Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | < | 0.1 | nM | 17958396 |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | < | 0.1 | nM | 17958396 |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | < | 0.1 | nM | 17958396 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | < | 0.1 | nM | 17958396 |
NPT2 | Others | Unspecified | GI50 | = | 48 | nM | 10096871 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 8.2 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | GI50 | = | 5 | nM | DrugMatrix in vivo data: Pathology | |
NPT168 | Cell Line | P388 | Mus musculus | GI50 | < | 0.1 | nM | 22652254 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 470 | nM | 23807823 |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | = | 25 | nM | 24900219 |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | = | 138 | nM | 24900219 |
NPT605 | Organism | Homo sapiens | Homo sapiens | ED50 | = | 0.052 | nM | 24900219 |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.0001 | nM | 21570837 |
NPT306 | Cell Line | PC-3 | Homo sapiens | ED50 | = | 0.0021 | nM | 21570837 |
NPT2 | Others | Unspecified | ED50 | = | 0.41 | nM | 21570837 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | ED50 | = | 30 | nM | 24900219 |
NPT376 | Cell Line | A498 | Homo sapiens | ED50 | = | 0.00055 | nM | 24900219 |
NPT81 | Cell Line | A549 | Homo sapiens | ED50 | = | 3.00E-05 | nM | 21524573 |
NPT605 | Organism | Homo sapiens | Homo sapiens | ED50 | = | 38 | nM | 21517059 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 50 | nM | 25920564 |
NPT2 | Others | Unspecified | GI50 | < | 0.1 | nM | 16038546 | |
NPT4859 | Cell Line | NCI | GI50 | = | 16 | nM | 20045651 | |
NPT517 | Cell Line | Panel NCI-60 (60 carcinoma cell lines) | Homo sapiens | GI50 | = | 50 | nM | 20045651 |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | = | 480 | nM | 20045651 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 27 | nM | 20045651 |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | = | 11 | nM | 20045651 |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | = | 271 | nM | 24507923 |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | = | 23 | nM | 24507923 |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | = | 7.9 | nM | 24507923 |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | = | 31 | nM | 24507923 |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | = | 37 | nM | 24507923 |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | < | 0.1 | nM | 22871217 |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | = | 110 | nM | 10.1584/jpestics.16.93 |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | < | 0.1 | nM | 20695427 |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | < | 0.1 | nM | 20695427 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC471558 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
NPC |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC471558 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
NPD |
PubChem CID   | 44448143 |
ChEMBL   | CHEMBL256973 |
ZINC   |
Molecular Weight:   | 914.53 |
ALogP:   | |
MLogP:   | 5.86 |
XLogP:   | 2.129 |
# Rotatable Bonds:   | 15 |
Polar Surface Area:   | |
# H-Bond Aceptor:   | 13 |
# H-Bond Donor:   | 7 |
# Rings:   | 0 |
# Heavy Atoms:   | 66 |